A new narrative review led by researchers at UCL and Birmingham Children’s Hospital has found there is a lack of evidence to demonstrate the effective use of continuous glucose monitors (CGMs) in people not living with diabetes (PNLD).
SynBiotic SE (von NuWays AG) – Biotech Investments
Original-Research: SynBiotic SE – from NuWays AG 17.09.2024 / 09:01 CET/CESTDissemination of a Research, transmitted by EQS News – a service of EQS Group AG.The